Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Protara Completes Enrollment in Phase 2b Portion of IV Choline Chloride Trial

Protara Completes Enrollment in Phase 2b Portion of IV Choline Chloride Trial

BitgetBitget2026/10/15 12:01
  • Protara Therapeutics completed enrollment of 24 patients in the Phase 2b dose-confirmation portion of its registrational THRIVE-3 trial of IV Choline Chloride.
  • The treatment targets choline deficiency in patients with intestinal failure who depend on parenteral support.
  • Interim Phase 2b results are expected in the fourth quarter of 2026; the study will guide dose selection.
  • The randomized, placebo-controlled Phase 3 portion will enroll approximately 100 patients to evaluate improvement in plasma choline levels and safety.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protara Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610150800PRIMZONEFULLFEED9846094) on October 15, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI agents break free from smartphones! Meta (META.US) launches new AI device Muse Charm priced at $300, including one year of Verizon (VZ.US) 5G data plan.

Meta plans to price its new AI hardware device, Muse Charm, at $300 and will offer buyers up to 12 months of free 5G data service from Verizon (VZ.US).

智通财经•2026/11/20 03:31
AI agents break free from smartphones! Meta (META.US) launches new AI device Muse Charm priced at $300, including one year of Verizon (VZ.US) 5G data plan.

Anthropic (ANT.US) IPO Spurs Forex Demand as Fed Rate Hike Expectations Rise, Dollar Poised for Fourth Weekly Gain

With the epic initial public offering (IPO) of Anthropic (ANT.US) further boosting demand for the US dollar, coupled with market expectations of additional interest rate hikes by the Federal Reserve and sustained high US Treasury yields, the dollar is poised to achieve its fourth consecutive weekly gain.

智通财经•2026/11/20 03:06
Anthropic (ANT.US) IPO Spurs Forex Demand as Fed Rate Hike Expectations Rise, Dollar Poised for Fourth Weekly Gain